A spate of human genetic studies has identified mutations in NMDAR subunits as a root cause of idiopathic focal epilepsy, a common childhood form of the disease. The studies suggest that a group of epilepsies and encephalopathies marked by seizures, aphasia and learning disorders could be treated with NMDAR-selective modulators.